News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult ADHD
Mind Medicine (MindMed)
atai Impact Establishes the atai Fellowship Fund in Psychedelic Neuroscience with Massachusetts General Hospital’s Center for the Neuroscience of Psychedelics
ATAI Life Sciences
Ketamine One Reports Strong 1Q22 Financial Results
Wellbeing Digital Sciences
Nova Mentis and Mycrodose Therapeutics Announce Major Milestone with Transdermal Technology for Fragile X Syndrome Clinical Program
Nova Mentis Life Science
Blackhawk Growth Announces Plan to Spin-Out Psychedelic Subsidiaries and Proposes 1:1 Distribution Ratio
MindBio Therapeutics
Apeiron and Other Key Shareholders of atai Life Sciences Reinforce Support by Entering into Extended, Voluntary Share Lock-up Agreements
ATAI Life Sciences
Ketamine One Announces Lifting Of Management Cease Trade Order
Wellbeing Digital Sciences
Ketamine One Appoints Joe Ramelli as Its New Chief Financial Officer
Wellbeing Digital Sciences
MAPS and Wesana Health Resume Negotiations
Wesana Health
Braxia Scientific Achieves Milestone as Landmark Psilocybin Clinical Trial Commences, Participants Receive First Doses of Psilocybin
Braxia Scientific Corp.
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.